Non-neurogenic elimination disorders in children

Journal of Pediatric Urology

Volumn 6, Issue 4, 2010, Pages 338-345

  Leclair, Marc David ^a   Héloury, Yves ^b  

^a Hopital Mere Enfant CHU de Nantes   (France)

^b MONASH MEDICAL CENTRE   (Australia)

Author keywords

Dysfunctional elimination syndrome; Hinman syndrome; Non neurogenic neurogenic bladder; Overactive bladder; Voiding dysfunction

Indexed keywords

ALFUZOSIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BOTULINUM TOXIN A; CHOLINERGIC RECEPTOR BLOCKING AGENT; COTRIMOXAZOLE; DOXAZOCIN; METHYLPHENIDATE; NITROFURANTOIN; OXYBUTYNIN; PLACEBO; PROPIVERINE; TOLTERODINE; TRIMETHOPRIM; TROSPIUM CHLORIDE; UNCLASSIFIED DRUG;

ANTIBIOTIC PROPHYLAXIS; ANTICHOLINERGIC EFFECT; BLADDER CONTRACTION; BLADDER DISEASE; BLADDER DYSFUNCTION; BLADDER FILLING; BLADDER INSTABILITY; CONSTIPATION; DETRUSOR MUSCLE; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; DYSFUNCTIONAL ELIMINATION SYNDROME; ENURESIS; EXTRAORDINARY DAYTIME URINARY FREQUENCY; FEEDBACK SYSTEM; FLUSHING; GIGGLE INCONTINENCE; HINMAN SYNDROME; HUMAN; INCONTINENCE; MICTURITION; MICTURITION DISORDER; NEUROGENIC BOWEL; OVERACTIVE BLADDER; PELVIC FLOOR MUSCLE TRAINING; POSTVOID DRIBBLING; POSTVOID RESIDUAL URINE VOLUME; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SPHINCTER; STRESS INCONTINENCE; URINARY TRACT DISEASE; URINE INCONTINENCE; XEROSTOMIA; CHILD; URINARY BLADDER, NEUROGENIC; URINARY INCONTINENCE; URINATION DISORDERS;

CHILD; HUMANS; URINARY BLADDER, NEUROGENIC; URINARY INCONTINENCE; URINATION DISORDERS;

EID: 77956732872     PISSN: 14775131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpurol.2010.01.006     Document Type: Review

References (74)

1. C.K. Yeung Pathophysiology of bladder dysfunction J.P. Gearhart, R.C. Rink, P.D.E. Mouriquand, Pediatric urology 2001 WB Saunders Philadelphia 453 469
2. I. Franco Overactive bladder in children. Part 1: pathophysiology J Urol 178 3 Pt 1 2007 761 768 discussion 8 (Pubitemid 47211056)
3. J.D. van Gool, and G.A. de Jonge Urge syndrome and urge incontinence Arch Dis Child 64 1989 1629 1634
4. Y.L. Homsy, I. Nsouli, B. Hamburger, I. Laberge, and E. Schick Effects of oxybutynin on vesicoureteral reflux in children J Urol 134 1985 1168 1171
5. S.A. Koff Relationship between dysfunctional voiding and reflux J Urol 148 5 Pt 2 1992 1703 1705
6. S.A. Koff, J. Lapides, and D.H. Piazza Association of urinary tract infection and reflux with uninhibited bladder contractions and voluntary sphincteric obstruction J Urol 122 1979 373 376
7. S.A. Koff, and D. Murtagh The uninhibited bladder in children: effect of treatment on vesicoureteral reflux resolution Contrib Nephrol 39 1984 211 220
8. S.A. Koff, and D.S. Murtagh The uninhibited bladder in children: effect of treatment on recurrence of urinary infection and on vesicoureteral reflux resolution J Urol 130 1983 1138 1141
9. G. Clayden, and A. Wright Constipation and incontinence in childhood: two sides of the same coin? Arch Dis Child 92 2007 472 474
10. S. Halachmi, and W.A. Farhat The impact of constipation on the urinary tract system Int J Adolesc Med Health 20 2008 17 22
11. I. Franco Overactive bladder in children. Part 2: management J Urol 178 3 Pt 1 2007 769 774 discussion 74 (Pubitemid 47211103)
12. L.A. Arya, D.L. Myers, and N.D. Jackson Dietary caffeine intake and the risk for detrusor instability: a case-control study Obstet Gynecol 96 2000 85 89
13. P. Sureshkumar, W. Bower, J.C. Craig, and J.F. Knight Treatment of daytime urinary incontinence in children: a systematic review of randomized controlled trials J Urol 170 2003 196 200 discussion 200
14. D. Marschall-Kehrel, C. Feustel, C. Persson de Geeter, M. Stehr, C. Radmayr, and U. Sillén Treatment with propiverine in children suffering from nonneurogenic overactive bladder and urinary incontinence: results of a randomized placebo-controlled phase 3 clinical trial Eur Urol 182 2009 2022 2026
15. K. Youdim, and B.A. Kogan Preliminary study of the safety and efficacy of extended-release oxybutynin in children Urology 59 2002 428 432
16. Y. Reinberg, J. Crocker, J. Wolpert, and D. Vandersteen Therapeutic efficacy of extended release oxybutynin chloride, and immediate release and long acting tolterodine tartratein children with diurnal urinary incontinence J Urol 169 2003 317 319
17. P. Hoebeke, K. De Caestecker, J. Vande Walle, J. Dehoorne, A. Raes, and P. Verleyen The effect of botulinum-A toxin in incontinent children with therapy resistant overactive detrusor J Urol 176 2006 328 330 discussion 30-1
18. M. Chandra, R. Saharia, Q. Shi, and V. Hill Giggle incontinence in children: a manifestation of detrusor instability J Urol 168 2002 2184 2187 discussion 7
19. B. Wefer, C. Seif, C. van der Horst, K.P. Junemann, and P.M. Braun [Botulinum toxin A injection for treatment-refractory giggle incontinence] Urologe A 46 2007 773 775
20. P.K. Sher, and Y. Reinberg Successful treatment of giggle incontinence with methylphenidate J Urol 156 2 Pt 2 1996 656 658
21. A.K. Berry, S. Zderic, and M. Carr Methylphenidate for giggle incontinence J Urol 2009 Aug 18
22. A.H. Rubenstein Obesity: a modern epidemic Trans Am Clin Climatol Assoc 116 2005 103 111
23. G.M. Nixon, J.A. Glazner, J.M. Martin, and S.M. Sawyer Urinary incontinence in female adolescents with cystic fibrosis Pediatrics 110 2002 e22
24. R.S. Asnes, and R.L. Mones Extraordinary urinary frequency Pediatrics 87 1991 953
25. J.W. Brock 3rd The frequency and frequency dysuria syndromes of childhood: hypercalciuria as a possible etiology Urology 44 1994 411 412
26. D.J. Parekh, J.I. Pope, M.C. Adams, and J.W. Brock 3rd The role of hypercalciuria in a subgroup of dysfunctional voiding syndromes of childhood J Urol 164 3 Pt 2 2000 1008 1010
27. M. Bergmann, T. Corigliano, I. Ataia, R. Renella, G.D. Simonetti, and M.G. Bianchetti Childhood extraordinary daytime urinary frequency - a case series and a systematic literature review Pediatr Nephrol 24 2009 789 795
28. S.A. Koff, T.T. Wagner, and V.R. Jayanthi The relationship among dysfunctional elimination syndromes, primary vesicoureteral reflux and urinary tract infections in children J Urol 160 3 Pt 2 1998 1019 1022
29. J.J. Chen, W. Mao, K. Homayoon, and G.F. Steinhardt A multivariate analysis of dysfunctional elimination syndrome, and its relationships with gender, urinary tract infection and vesicoureteral reflux in children J Urol 171 2004 1907 1910
30. J. Van Gool, and E.A. Tanagho External sphincter activity and recurrent urinary tract infection in girls Urology 10 1977 348 353
31. A.S. Feldman, and S.B. Bauer Diagnosis and management of dysfunctional voiding Curr Opin Pediatr 18 2006 139 147
32. L.M. Perez, and H.G. Rushton A pragmatic approach to the evaluation and management of non-neuropathic daytime voiding disorders J.P. Gearhart, R.C. Rink, P.D.E. Mouriquand, Pediatric urology 2001 WB Saunders Philadelphia 470 495
33. E. Merlini, L. Sangiorgio, and P. Seymandi The lazy bladder syndrome: a possible urodynamic evolution in patients with idiopathic detrusor and pelvic floor overactivity Pediatr Med Chir 26 2004 187 190
34. R.J. Nijman Role of antimuscarinics in the treatment of nonneurogenic daytime urinary incontinence in children Urology 63 Suppl. 1 2004 45 50
35. S.B. Bauer, A.B. Retik, A.H. Colodny, M. Hallett, S. Khoshbin, and F.M. Dyro The unstable bladder in childhood Urol Clin North Am 7 1980 321 336
36. P.I. Ellsworth, P.A. Merguerian, and M.E. Copening Sexual abuse: another causative factor in dysfunctional voiding J Urol 153 3 Pt 1 1995 773 776
37. C.K. Yeung, M.L. Godley, H.K. Dhillon, P.G. Duffy, and P.G. Ransley Urodynamic patterns in infants with normal lower urinary tracts or primary vesico-ureteric reflux Br J Urol 81 1998 461 467
38. C.K. Yeung, M.L. Godley, P.G. Duffy, and P.G. Ransley Natural filling cystometry in infants and children Br J Urol 75 1995 531 537
39. C.K. Yeung The normal infant bladder Scand J Urol Nephrol Suppl 173 1995 19 23
40. M. Bachelard, U. Sillen, S. Hansson, G. Hermansson, U. Jodal, and B. Jacobsson Urodynamic pattern in asymptomatic infants: siblings of children with vesicoureteral reflux J Urol 162 1999 1733 1737 discussion 7-8
41. M.L. Godley, D. Desai, C.K. Yeung, H.K. Dhillon, P.G. Duffy, and P.G. Ransley The relationship between early renal status, and the resolution of vesico-ureteric reflux and bladder function at 16 months BJU Int 87 2001 457 462
42. S. Sjostrom, U. Sillen, M. Bachelard, S. Hansson, and E. Stokland Spontaneous resolution of high grade infantile vesicoureteral reflux J Urol 172 2004 694 698 discussion 9
43. U. Sillen Bladder dysfunction and vesicoureteral reflux Adv Urol 2008 815472
44. J.D. van Gool, K. Hjalmas, T. Tamminen-Mobius, and H. Olbing Historical clues to the complex of dysfunctional voiding, urinary tract infection and vesicoureteral reflux. The International Reflux study in children J Urol 148 5 Pt 2 1992 1699 1702
45. V. Loening-Baucke Prevalence rates for constipation and faecal and urinary incontinence Arch Dis Child 92 2007 486 489
46. S. Halachmi, and W.A. Farhat Interactions of constipation, dysfunctional elimination syndrome, and vesicoureteral reflux Adv Urol 2008 828275
47. E. Beer Chronic retention of urine in children JAMA 1915 65
48. F. Hinman Jr. Nonneurogenic neurogenic bladder (the Hinman syndrome) - 15 years later J Urol 136 1986 769 777
49. T.D. Allen The non-neurogenic neurogenic bladder J Urol 117 1977 232 238
50. B. Ochoa The urofacial (Ochoa) syndrome revisited J Urol 148 2 Pt 2 1992 580 583
51. B. Ochoa, and R.J. Gorlin Urofacial (ochoa) syndrome Am J Med Genet 27 1987 661 667
52. C.Y. Wang, A. Davoodi-Semiromi, J.D. Shi, P. Yang, Y.Q. Huang, and J.A. Agundez High resolution mapping and mutation analyses of candidate genes in the urofacial syndrome (UFS) critical region Am J Med Genet A 119A 2003 9 14
53. V.R. Jayanthi, A.E. Khoury, G.A. McLorie, and S.K. Agarwal The nonneurogenic neurogenic bladder of early infancy J Urol 158 1997 1281 1285
54. A. Cheikhelard, D. Chaouadi, Y. Teklali, and P.D.E. Mouriquand Non obstructive congenital bladder and intestinal dysfunction (NOCOBLIND) J Pediatr Urol 2 2006 1
55. I. Vidal, Y. Heloury, P. Ravasse, L. Lenormand, and M.D. Leclair Severe bladder dysfunction revealed prenatally or during infancy J Pediatr Urol 5 2009 3 7
56. J.A. Kari Neuropathic bladder as a cause of chronic renal failure in children in developing countries Pediatr Nephrol 21 2006 517 520
57. C. Garignon, P.Y. Mure, P. Paparel, D. Chiche, and P. Mouriquand [Severe bladder dysfunction in the child abuse victim. Hinman syndrome] Presse Med 30 39-40 Pt 1 2001 1918 1923
58. L.N. Handel, A. Barqawi, G. Checa, P.D. Furness 3rd, and M.A. Koyle Males with Down's syndrome and nonneurogenic neurogenic bladder J Urol 169 2003 646 649
59. N. Kai, N. Seki, A. Hirata, S. Nakamuta, and S. Naito A female case with Down syndrome and non-neurogenic neurogenic bladder Int J Urol 14 2007 867 868
60. H. De Paepe, C. Renson, P. Hoebeke, A. Raes, E. Van Laecke, and J. Vande Walle The role of pelvic-floor therapy in the treatment of lower urinary tract dysfunctions in children Scand J Urol Nephrol 36 2002 260 267
61. A.J. Combs, A.D. Glassberg, D. Gerdes, and M. Horowitz Biofeedback therapy for children with dysfunctional voiding Urology 52 1998 312 315
62. P. Lopez-Pereira, C. Miguelez, J. Caffarati, F. Estornell, and A. Anguera Trospium cholride for the treatment of detrusor inctability in children J Urol 170 2003 1978 1981
63. M.P. Cain, S.D. Wu, P.F. Austin, C.D. Herndon, and R.C. Rink Alpha-blocker therapy for children with dysfunctional voiding and urinary retention J Urol 170 2003 1514 1515
64. R. DasGupta, and F.L. Murphy Botulinum toxin in paediatric urology: a systematic literature review Pediatr Surg Int 25 2009 19 23
65. B. Schurch, M. Stohrer, G. Kramer, D.M. Schmid, C. Gaul, and D. Hauri Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results J Urol 164 2000 692 697
66. A. Reitz, M. Stohrer, G. Kramer, G. Del Popolo, E. Chartier Kastler, and J. Panek European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity Eur Urol 45 2004 510 515
67. B. Schurch, M. de Seze, P. Denys, E. Chartier Kastler, F. Haab, and K. Everaert Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo-controlled 6-month study J Urol 174 2005 196 200
68. A. Sahai, M.S. Khan, and P. Dasgupta Efficacy of botulinum toxin-A for treating detrusor overactivity: results from a single center, randomized, double-blind, placebo-controlled trial J Urol 177 2007 2231 2236
69. M.W. Phelan, M. Franks, G.T. Somogyi, T. Yokoyama, M.O. Fraser, and J.P. Lavelle Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction J Urol 165 2001 1107 1110
70. Z.I. Radojicic, S. Perovic, and N.M. Milic Is it reasonable to treat refractory voiding dysfunction in children with botulinum-A toxin? J Urol 176 2006 332 336
71. J.M. Guys, M. Haddad, D. Planche, M. Torre, C. Louis-Borrione, and J. Breaud Sacral neuromodulation for neurogenic bladder dysfunction in children J Urol 172 2004 1673 1676
72. P. Hoebeke, E. Van Laecke, K. Everaert, C. Renson, H. De Paepe, and A. Raes Transcutaneous neuromodulation for the urge syndrome in children: a pilot study J Urol 166 2001 2416 2419
73. T.J. Roth, D.R. Vandersteen, P. Hollatz, B.A. Inman, and Y.E. Reinberg Sacral neuromodulation for the dysfunctional elimination syndrome: a single centre experience with 20 children J Urol 180 2008 306 311
74. A.J. Combs Re: sacral neuromodulation for the dysfunctional elimination syndrome: a single centre experience with 20 children J Urol 180 2008 311